Keyphrases
ACE Inhibitors
20%
African American
100%
Angiotensin Receptor Blockers
20%
Average Effect
20%
Beta-blockers
20%
Black Men
40%
Clinical Trials
20%
Effective Therapy
20%
Heart Failure Treatment
100%
Heart Failure Trials
40%
Hydralazine
20%
Hypertension
20%
Intervention Effect
20%
Nitrate
20%
Patients with Heart Failure
20%
Physiologic
20%
Response to Therapy
20%
White Patients
20%
White People
40%
Agricultural and Biological Sciences
ACE Inhibitor
20%
African
100%
Americans
100%
Angiotensin
20%
Eicosanoid Receptor
20%
Hydralazine
20%
Receptor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Receptor Antagonist
25%
Clinical Trial
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Heart Failure
100%
Hydralazine
25%
Medicine and Dentistry
ACE Inhibitor
25%
Angiotensin Receptor Antagonist
25%
Clinical Trial
25%
Heart Failure
100%
Hydralazine
25%
Nursing and Health Professions
Angiotensin Receptor Antagonist
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Heart Failure
100%
Hydralazine
25%